Literature DB >> 30230597

Identification specific miRNA in t(4;14) multiple myeloma based on miRNA-mRNA expressing profile correlation analysis.

Huimin Liu1,2, Guihua Wang1,2, Ying Huang1,2, Chunmei Zhao1,2, Jing Chen1,2, Xudong Wang1,2,3.   

Abstract

BACKGROUND: Multiple myeloma (MM) is a common malignancy belonging to the hematological system. The translocation t(4;14)(p16.3;q32.3) is a critical cytogenetic change of MM, which is presenting a poor prognosis. The specific microRNAs (miRNAs) that are involved in t(4;14) myeloma are still unknown. Thus, the main purpose of this research was to identify specific miRNAs in t(4;14) positive myeloma.
METHODS: The expression profiles of miRNA and messenger RNA (mRNA) in t(4; 14) positive and negative samples were obtained from the gene expression omnibus data series. The miRNA-mRNA regulatory network was constructed based on two self-defined regulation models. Subsequently, we performed the topology analysis for mining the hub genes, and Pearson's correlation coefficient analysis was used to calculate the relevance of the hub genes and specific miRNAs.
RESULTS: Thirteen differentially expressed miRNAs and 206 differential mRNAs were extracted between t(4;14) positive group and negative group. The network consisted of 8 miRNAs and 154 mRNAs in 2 reverse regulated models, which showed a total of 485 interactions, including 376 cis-regulated and 109 trans-regulated relationships. The miR-125a-3p, miR-125a-5p, miR-99b-5p, and let-7e were powerful miRNAs correlating with the FGFR3, MAP1B, MYRIP, and CDC42BPA under the relevance analysis in the subnetwork.
CONCLUSION: In our study, a distinctive correlation analysis of miRNA-mRNA was established to excavate specific miRNAs and hub target mRNAs in patients with t(4;14), but it was only a matter of theoretical principles. The further experimental explorations are needed to confirm valuable diagnostic and therapeutic symbols specific associated with t(4;14) in the future.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Fisher’s exact test; messenger RNA (mRNA) expression; microRNA (miRNA) expression; microRNA-mRNA network; t(4;14) multiple myeloma (MM); target genes prediction

Year:  2018        PMID: 30230597     DOI: 10.1002/jcb.27537

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  4 in total

1.  Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging.

Authors:  Zehua Zhu; Zhaojun Chen; Mingxing Wang; Min Zhang; Yiwen Chen; Xiao Yang; Changjun Zhou; Yuhua Liu; Liquan Hong; Lahong Zhang
Journal:  J Ovarian Res       Date:  2022-02-19       Impact factor: 4.234

2.  Relation among EGFL7, ITGB3, and KLF2 and their clinical implication in multiple myeloma patients: a prospective study.

Authors:  Yaqiong Li; Lingli Zhang; Jichang Gong
Journal:  Ir J Med Sci       Date:  2021-10-11       Impact factor: 2.089

3.  PCAT-1 promotes cell growth by sponging miR-129 via MAP3K7/NF-κB pathway in multiple myeloma.

Authors:  Xianjuan Shen; Shan Kong; Qian Yang; Qingqing Yin; Hui Cong; Xudong Wang; Shaoqing Ju
Journal:  J Cell Mol Med       Date:  2020-02-12       Impact factor: 5.310

4.  Potential of microRNA expression profile in predicting renal impairment risk in multiple myeloma patients.

Authors:  Daijin Ren; Yuwen Cai; Gaosi Xu
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.